A MULTINATIONAL, MULTICENTER STUDY TO ASSESS THE EFFECTS OF ORAL SILDENAFIL ON MORTALITY IN ADULTS WITH PULMONARY ARTERIAL HYPERTENSION (PAH)
A MULTINATIONAL, MULTICENTER STUDY TO ASSESS THE EFFECTS OF ORAL SILDENAFIL ON MORTALITY IN ADULTS WITH PULMONARY ARTERIAL HYPERTENSION (PAH)
This is a blinded study in adult patients with PAH evaluating the relative effects of sildenafil on mortality when administered at the three doses (80 mg, 20 mg or 5 mg, all three times per day [TID]). In addition, the relative effects on clinical worsening and 6-minute walking distance (6MWD) will be assessed.
Inclusion Criteria:
Subjects ≥ 18 <75 years of age with any of the following conditions:
Exclusion Criteria:
Grand Rapids, Michigan 49503, United States
Banja Luka, B&h/republic of Srpska 78000, Bosnia and Herzegovina
Sarajevo, Bosnia and Herzegovina/canton Sarajevo 71000, Bosnia and Herzegovina
Tuzla, Canton Tuzla 75000, Bosnia and Herzegovina
Shatin, New Territories, Hong Kong
Monterrey, Nuevo León 64460, Mexico
Târgu Mureş, 540136, Romania
Saint Petersburg, Russian Federation 197341, Russia
Singapore, 119228, Singapore
Pathumwan, Bangkok 10330, Thailand
Pathumwan, Bangkok 10330, Thailand
Muang District, Changwat Khon Kaen 40002, Thailand
Muang District, Changwat Khon Kaen 40002, Thailand
Muang District, Changwat Khon Kaen 40002, Thailand
Muang, Chiang Mai 50200, Thailand
Sripoom Sub-district, Muang, Chiang Mai 50200, Thailand
Izmir, Inciralti 35340, Turkey (Türkiye)
Kyiv, 01601, Ukraine
M. Dnipro, 49044, Ukraine